COVID-19 Emergency Measures
Click here for information on LA HAP’s response to the COVID-19 emergency (updated 4/7/20).
Read moreSuboxone added to uninsured formulary, 2020 FPIG in effect
Click here for the 3/2/20 LA HAP Bulletin.
Read moreNew in 2020: documentation grace period, Marketplace documentation due, Naloxone added to uninsured formulary, Medicare General Enrollment
Click here for the 1/2/20 LA HAP Bulletin.
Read moreLA HAP Policy Change on Low Income Subsidy for Medicare Beneficiaries
Click here for the 10/7/19 LA HAP Bulletin.
Read moreFactsheet on Accessing Care for Dual Eligible Clients
Click here for the 8/5/19 LA HAP Bulletin.
Read moreChanges to dental coverage policy for non-Guardian clients
LA HAP Bulletin for 5/20/19 Changes to dental coverage policy for non-Guardian clients Please read this bulletin carefully. If you have questions about the upcoming changes, join LA HAP staff for a brief call on Thursday, May 23 rd...
Read moreTemporary staff change, 2018 tax filing
LA HAP Bulletin for 4/15/19 Temporary staff change One of our Client Services Specialists, Cherrika Lewis, is on extended leave until further notice. Until she is back with us, please contact Erin (504-568-3623) for any follow-up regarding applications on...
Read moreInformation for Medicaid enrollees and dual eligible LA HAP clients
LA HAP Bulletin for 3/26/19 Information for Medicaid enrollees and dual eligible LA HAP clients During a time of transition for Medicaid and based on your feedback, LA HAP would like to issue some reminders to our community. Medicaid...
Read moreSymfi, Symfi Lo, and Cimduo added to formulary, 2019 FPIG in effect
LA HAP Bulletin for 3-7-19 SYMFI, SYMFI LO, and CIMDUO added to LA HAP formulary Effective 3/1/19, LA HAP has added SYMFI (efavirenz [600 mg]/tenofovir disproxil/lamivudine), SYMFI LO (efavirenz [400 mg]/tenofovir disproxil/lamivudine) and CIMDUO (tenofovir disoproxil fumarate/lamivudine) to the...
Read more